Location notice: Etobicoke hours changed Sept. 10; the clinic is now closed Fridays.
View hoursSLOW-RELEASE ORAL MORPHINE
Learn about Kadian / slow-release oral morphine as a physician-led opioid agonist treatment option and how TSCP coordinates medical and pharmacy follow-up.
Answer first
Slow-release oral morphine (SROM), including Kadian, can be used as an opioid agonist treatment option in Canada. At TSCP it is considered only when clinically appropriate after physician assessment.
Opioid use disorder, when clinically appropriate
SROM is a long-acting opioid agonist option used in some opioid-use-disorder treatment pathways. It is not the right medication for every patient, and selection must be based on an individualized medical assessment.
A physician assessment before any medication decision.
A discussion of prior treatment, current needs and the reason SROM may or may not fit.
Ongoing medical monitoring and medication management.
Pharmacy coordination where the medication is prescribed and available.
Integrated care
TSCP's clinic-and-pharmacy model helps keep prescribing, dispensing and pharmacist support connected when this medication is prescribed and available through the location.
Related care
TSCP treats opioid use disorder through physician-led assessment and opioid agonist treatment when clinically appropriate. Medication options can include Methadone, Suboxone or Kadian/SROM, with ongoing medical and pharmacy follow-up.
Explore programTSCP can assess and treat opioid use disorder related to fentanyl. A physician reviews the person's opioid use, health risks, previous treatment and goals before deciding whether Methadone, Suboxone or Kadian/SROM may be appropriate.
Explore programHeroin use can lead to opioid use disorder. TSCP provides medical assessment and can offer opioid agonist treatment when clinically appropriate, with medication selection based on individual clinical needs.
Explore programTSCP can assess problematic oxycodone use and determine whether it represents physical dependence, opioid use disorder or another clinical concern. If opioid use disorder is diagnosed, opioid agonist treatment may be considered when appropriate.
Explore programCommon questions
No. A clinician determines whether a medication is appropriate after reviewing your diagnosis, health history, current substance use and prior treatment.
Treatment duration varies. Ongoing follow-up is individualized and should not be stopped or changed without guidance from the treating clinician.
TSCP uses an integrated clinic-and-pharmacy model. Confirm medication availability and the pharmacy workflow with the location involved in your care.
Editorial transparency
Prepared by the TSCP editorial team using Canadian public-health and clinical sources. A named medical reviewer is not displayed until TSCP confirms the reviewer and credentials.
Content updated: 2026-09-10
Four GTA clinics
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
TSCP clinic
Clinic and integrated pharmacy support. Confirm treatment availability for your specific plan with the location.
